Jardiance 25 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F4E3D
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $87,244
Award facts
- Contract value 100% obligated
- $87,243.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $87,243.84 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units). This competitively awarded, firm fixed-price delivery order was issued on January 5, 2026, with an ultimate completion date of January 6, 2026. The contract carries no set-aside designation, and performance is based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vehicle through December 2026 that serves as a comprehensive pharmaceutical support contract for military healthcare systems.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical supplies and medications to federal healthcare systems, particularly the Department of Defense and veteran healthcare networks. As a primary vendor under the DLA's pharmaceutical supply chain, the company supplies a diverse portfolio of brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains. The company's demonstrated capability to fulfill federal procurement requirements through open competition, combined with its extensive experience managing large-scale pharmaceutical delivery orders, positions it as a key supplier for military medical logistics. The DLA is currently planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts with multiple regional awards, reflecting the continued importance of vendor relationships like AmerisourceBergen's in supporting global military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F4E3D?
SPE2DR26F4E3D was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26F4E3D worth?
The government has obligated $87,244 on SPE2DR26F4E3D.
Is contract SPE2DR26F4E3D an order under another contract?
Yes. SPE2DR26F4E3D is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4E3D competed?
The extent of competition for SPE2DR26F4E3D was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award